Revista Colombiana de Reumatología (English Edition)最新文献

{"title":"Clinical practice guideline for the prevention, diagnosis, and treatment of glucocorticoid-induced osteoporosis. Colombian Association of Rheumatology, 2023","authors":"Monique Chalem ,&nbsp;Noemi Casas ,&nbsp;Aura María Domínguez ,&nbsp;Daniel Gerardo Fernández ,&nbsp;Andrés González ,&nbsp;Edwin Jáuregui ,&nbsp;José Fernando Molina ,&nbsp;Diana Nathalie Rincón ,&nbsp;Carlos Enrique Toro-Gutiérrez ,&nbsp;Francisco Juan Vargas Grajales ,&nbsp;Susan Martínez ,&nbsp;Linda Ibatá","doi":"10.1016/j.rcreue.2024.07.005","DOIUrl":"10.1016/j.rcreue.2024.07.005","url":null,"abstract":"<div><p>The use of glucocorticoids is the most frequent cause of osteoporosis and osteoporotic fractures. Considering that glucocorticoid-induced osteoporosis (GIOP) is an underestimated and generally untreated problem, the Bone Metabolism study group of the Colombian Association of Rheumatology decided to create this Clinical Practice Guideline (CPG) in order to support rheumatologists and other specialists in the country who use this type of medication to manage inflammatory and autoimmune conditions, with recommendations on prevention, diagnosis, and treatment of GIOP. The recommendations presented here were constructed following the GRADE-ADOLOPMENT methodology. The American College of Rheumatology guideline, Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis, was selected as the source for updating the literature searches. The development of this CPG also included the participation of clinical experts from different specialties, patients, and the EpiThink Health Consulting technical-methodological team.</p></div>","PeriodicalId":101099,"journal":{"name":"Revista Colombiana de Reumatología (English Edition)","volume":"31 3","pages":"Pages 365-379"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142272538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Clinical relationship between reactive arthritis and SARS-CoV-2 infection: A scoping review","authors":"Eduardo Tuta-Quintero ,&nbsp;Juan C. Santacruz ,&nbsp;Julián Camacho ,&nbsp;Juan Olivella ,&nbsp;Estefanía Collazos ,&nbsp;Juan C. Gómez ,&nbsp;Damián A. Ochoa ,&nbsp;Jilmar Salazar-Villa ,&nbsp;José E. Rodríguez ,&nbsp;Daniela F. Pérez ,&nbsp;Julia Gutiérrez ,&nbsp;Rodrigo Sanabria-Sarmiento ,&nbsp;Camilo E. Herrera","doi":"10.1016/j.rcreue.2023.04.001","DOIUrl":"10.1016/j.rcreue.2023.04.001","url":null,"abstract":"<div><h3>Introduction</h3><p>Reactive arthritis (ReA) is a monoarthritis or oligoarthritis that mainly affects the extremities, it can be related to bacterial or viral infections. Currently, COVID-19 has been linked to the development of arthropathies due to its inflammatory component.</p></div><div><h3>Objective</h3><p>A scoping review of the literature that describes the clinical characteristics of ReA in survivors of SARS-CoV-2 infection.</p></div><div><h3>Materials and methods</h3><p>A systematic review based on the guidelines for reporting systematic reviews adapted for Prisma-P exploratory reviews and steps proposed by Arksey and adjusted by Levan. Experimental and observational studies published in PubMed and Scopus, English and Spanish, which answered the research questions posed, were included.</p></div><div><h3>Results</h3><p>Twenty-five documents were included describing the main clinical manifestations of ReA in 27 patients with a history of SARS-Cov-2 infection. The time from the onset of symptoms or microbiological diagnosis of COVID-19 to the development of articular and/or extra-articular manifestations compatible with ReA ranged from 7 days to 120 days. The clinical joint manifestations described were arthralgia and oedema, predominantly in knee, ankle, elbow, interphalangeal, metatarsophalangeal, and metacarpophalangeal joints.</p></div><div><h3>Conclusions</h3><p>Arthralgias in the extremities are the main symptom of ReA in patients with a history of COVID-19, whose symptoms can present in a period of days to weeks from the onset of clinical symptoms or microbiological diagnosis of SARS-CoV-2 infection.</p></div>","PeriodicalId":101099,"journal":{"name":"Revista Colombiana de Reumatología (English Edition)","volume":"31 3","pages":"Pages 390-398"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142272539","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Diffuse alveolar hemorrhage secondary to anti-synthetase syndrome","authors":"María Fernanda Castillo López ,&nbsp;Eric Andrey Rodríguez Vega ,&nbsp;Mayra Edith Mejía Ávila ,&nbsp;Jorge Rojas Serrano","doi":"10.1016/j.rcreue.2023.11.002","DOIUrl":"10.1016/j.rcreue.2023.11.002","url":null,"abstract":"<div><h3>Introduction</h3><p>Alveolar hemorrhage syndrome can be secondary to multiple autoimmune disorders. The objective is to describe three diffuse alveolar hemorrhage (DAH) cases secondary to anti-synthetase syndrome (ASSD).</p></div><div><h3>Presentation of the case</h3><p>Three cases of ADH secondary to ASSD are described: one positive to anti-PL7, another positive to anti-PL12, and the last patient with double positivity to anti-Jo1 and anti-OJ. The patients presented improvement after receiving immunosuppressive treatment.</p></div><div><h3>Discussion</h3><p>The evolution with therapeutic response and resolution of DAH supports the conclusion that ASSD is a potentially treatable cause of DAH and should be considered within the differential diagnosis in diagnosing DAH.</p></div><div><h3>Conclusion</h3><p>The described cases contribute to the knowledge of DAH, where ASSD should be considered in diagnosing DAH.</p></div>","PeriodicalId":101099,"journal":{"name":"Revista Colombiana de Reumatología (English Edition)","volume":"31 3","pages":"Pages 412-416"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142272541","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evaluating the efficacy and safety of sodium thiosulfate in calcific tendinitis of the rotator cuff – Data from an ongoing randomized clinical trial","authors":"Hugo Parente,&nbsp;Soraia Azevedo,&nbsp;Francisca Guimarães,&nbsp;Catarina Soares,&nbsp;Maria Ferreira,&nbsp;Daniela Santos-Faria,&nbsp;Daniela Peixoto,&nbsp;José Tavares-Costa,&nbsp;Carmo Afonso,&nbsp;Filipa Teixeira","doi":"10.1016/j.rcreue.2023.12.003","DOIUrl":"10.1016/j.rcreue.2023.12.003","url":null,"abstract":"","PeriodicalId":101099,"journal":{"name":"Revista Colombiana de Reumatología (English Edition)","volume":"31 3","pages":"Pages 424-425"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142272542","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Transient osteoporosis of pregnancy: A case series","authors":"Alberto Armijo Sánchez ,&nbsp;Isabel María Aguilar Gálvez ,&nbsp;Nahia Plaza Aulestia ,&nbsp;Bárbara Ramírez Muñoz ,&nbsp;Jordi Boned López","doi":"10.1016/j.rcreue.2024.07.001","DOIUrl":"10.1016/j.rcreue.2024.07.001","url":null,"abstract":"<div><p><span>Transient osteoporosis of pregnancy is a pathology of low prevalence and difficult diagnosis that mainly affects pregnant women in the </span>third trimester<span><span><span><span> of pregnancy. It is characterized by mechanical joint pain, more frequent in the lower limbs, radiological </span>osteopenia<span>, and bone oedema on magnetic resonance imaging (MRI). A series of 4 cases is presented in pregnant women between 26 weeks of gestation and the early puerperium with symptoms of coxalgia and/or knee pain. The treatment was based on conservative measures: </span></span>analgesics<span> that are allowed during pregnancy and non-weight bearing on the joints, and the possibility of corticosteroid infiltration into the joint. Bisphosphonates can be added in the puerperium. All cases resolved within a maximum of 9 months, without subsequent </span></span>sequelae.</span></p></div>","PeriodicalId":101099,"journal":{"name":"Revista Colombiana de Reumatología (English Edition)","volume":"31 3","pages":"Pages 417-423"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141850287","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Erratum to the article “Current status of musculoskeletal ultrasound in Colombian rheumatology” [Rev Colomb Reumatol. 2023;30(1):4-12]","authors":"Josué Guillermo López-Velandia ,&nbsp;Juliana Higuera-García ,&nbsp;Luis Javier Cajas-Santana","doi":"10.1016/j.rcreue.2024.07.006","DOIUrl":"10.1016/j.rcreue.2024.07.006","url":null,"abstract":"","PeriodicalId":101099,"journal":{"name":"Revista Colombiana de Reumatología (English Edition)","volume":"31 3","pages":"Page 426"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2444440524001158/pdfft?md5=ca75a3a41d9de9fe89bb1dd127141d4b&pid=1-s2.0-S2444440524001158-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142271852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Interstitial lung disease in patients with idiopathic inflammatory myopathy (IIM-ILD): Definitions, epidemiology, pathophysiology, clinical manifestations, complications, risk, and mortality factors (narrative review)","authors":"Andrés Hormaza-Jaramillo ,&nbsp;Liliana Fernandez-Trujillo ,&nbsp;Tatiana Delgado-Mora ,&nbsp;Carlos Julio Vargas-Potes","doi":"10.1016/j.rcreue.2023.08.002","DOIUrl":"10.1016/j.rcreue.2023.08.002","url":null,"abstract":"<div><p>Interstitial lung disease refers to a group of disorders generally characterized by progressive scarring of lung tissue due to a wide variety of causes and associated with a plethora of symptoms. Patients with this diagnosis can be asymptomatic or present severe symptoms that could lead to death. Its signs and symptoms are the same in patients with concomitant connective tissue disease and those without. Genetics and immunity play essential roles in patients with interstitial lung disease and idiopathic inflammatory myopathy. Alterations in genes and excessive production of specific cytokines can lead to the development of interstitial lung disease. Interstitial lung disease can have several complications, including chronic respiratory distress and infections, and can worsen the prognosis of patients with idiopathic inflammatory myopathy. Here, we present a narrative review describing the epidemiology, pathophysiology, clinical manifestations, risk factors, and complications of the population with interstitial lung disease and idiopathic inflammatory myopathy.</p></div>","PeriodicalId":101099,"journal":{"name":"Revista Colombiana de Reumatología (English Edition)","volume":"31 3","pages":"Pages 399-411"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142272540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Capillaroscopic abnormalities in systemic lupus erythematosus and its association with clinical manifestation","authors":"María Fernanda Álvarez Barreneche ,&nbsp;Carlos Jaime Velásquez Franco ,&nbsp;Carlos Esteban Giraldo Cuartas ,&nbsp;Miguel Antonio Mesa Navas","doi":"10.1016/j.rcreue.2023.05.004","DOIUrl":"10.1016/j.rcreue.2023.05.004","url":null,"abstract":"<div><h3>Introduction</h3><p>Capillaroscopy is a non-invasive tool used to evaluate microcirculation and determine whether a Raynaud's phenomenon is primary or secondary. Capillaroscopic changes are well-described in systemic sclerosis; however, these alterations have been less studied in other autoimmune diseases.</p></div><div><h3>Objective</h3><p>The aim of this study is to determine videocapillaroscopic alterations in lupus, and its association with clinical manifestations.</p></div><div><h3>Materials and methods</h3><p>A cross-sectional study with analytical intention was performed. Videocapillaroscopy and medical evaluations were performed on 76 patients with lupus, according to SLICC 2012 classificatory criteria, from January to June 2019. Chi², Fisher, and Mann–Whitney <em>U</em> tests were used to evaluate association, and the prevalence ratios (PR) were determined. A multivariate analysis was performed.</p></div><div><h3>Results</h3><p>Seventy-one (93.4%) of the patients were female with a median age of 33.5 years (interquartile range [IQR]: 27–44.8); the median lupus duration was 84 months (IQR: 30–168). The main clinical manifestations were articular, cutaneous, hematological, and Raynaud's phenomenon. A non-specific pattern was found in 43 patients (56.6%), and a systemic sclerosis-like pattern was found in 7 patients (9.2%). In bivariate and multivariate analyses, Raynaud episodes occurring more than once a week (PR 1.24; 95% CI: 1.13–1.33) were more frequent in patients with a sclerosis-like or a non-specific pattern.</p></div><div><h3>Conclusion</h3><p>Lupus patients frequently have videocapillaroscopic alterations with non-specific and systemic sclerosis like patterns, which are more common in patients with Raynaud's phenomenon that occurs more than once a week. Due to the study's design, it is impossible to determine causality.</p></div>","PeriodicalId":101099,"journal":{"name":"Revista Colombiana de Reumatología (English Edition)","volume":"31 3","pages":"Pages 304-310"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142271846","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Relapse in patients with ANCA-associated vasculitis: A cohort study from a centre for rheumatic diseases in Colombia","authors":"Ana María Romero-Millán ,&nbsp;Andrés Arango-Vieira ,&nbsp;Jaime Andrés Ibarra-Burgos ,&nbsp;Maria Antonia Mesa-Maya ,&nbsp;María José Orrego-Garay ,&nbsp;Santiago Gómez-Maya ,&nbsp;Tomás Giraldo-Hinestroza ,&nbsp;Fabio Torres-Saavedra ,&nbsp;Diego Fernando Rojas-Gualdrón ,&nbsp;Juan Camilo Díaz-Coronado","doi":"10.1016/j.rcreue.2024.08.002","DOIUrl":"10.1016/j.rcreue.2024.08.002","url":null,"abstract":"<div><h3>Introduction</h3><p>Relapses are common in patients with ANCA-associated vasculitis (AAV), which results in a significant burden of morbidity, mortality, impact on quality of life, disability, and cost. However, evidence in the Colombian population is scarce.</p></div><div><h3>Objective</h3><p>The objective of this study was to estimate the relapse-free survival during the first year and describe clinical and serological variables of patients with AAV in a specialized centre for rheumatic diseases in Colombia.</p></div><div><h3>Materials and methods</h3><p>A retrospective follow-up study was conducted on a cohort based on medical records of patients over 18 years old with confirmed diagnosis of AAV by the treating rheumatologist and who had achieved remission. Information on AAV relapse and clinical, immunoserological, and treatment-related characteristics was extracted. The relapse-free survival function during the first year was estimated.</p></div><div><h3>Results</h3><p>A total of 56 patients were included, 69.9% of whom were women, with a median age of 60 (IQR<!--> <!-->=<!--> <!-->48−63). According to the clinical phenotype, 64.3% were classified as granulomatosis with polyangiitis (GPA), 23.2% as microscopic polyangiitis (MPA), and 12.5% as eosinophilic granulomatosis with polyangiitis (EGPA). According to the European Vasculitis Study Group (EUVAS) classification, 39.3% had generalized AAV at debut, 23.2% had localized AAV, 21.4% had severe renal AAV, and 16.1% had systemic AAV. The median Five Factor Score (FFS) was 1 (IQR<!--> <!-->=<!--> <!-->0−2). The cumulative relapse-free survival at one year was 82.2%.</p></div><div><h3>Conclusions</h3><p>The relapse-free survival observed in this cohort was similar to other reports in clinical studies and AAV registries.</p></div>","PeriodicalId":101099,"journal":{"name":"Revista Colombiana de Reumatología (English Edition)","volume":"31 3","pages":"Pages 318-326"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142271848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Echocardiographic findings in patients with systemic lupus erythematosus: Retrospective analysis in a tertiary referral centre","authors":"Oswaldo E. Aguilar-Molina ,&nbsp;Diana Quintero-González ,&nbsp;Juan Corredor-Castro ,&nbsp;María Antonia Escobar-Mera ,&nbsp;Silvia Gironza Betancourt ,&nbsp;David Del Castillo-Gil ,&nbsp;Luis Fernando Medina-Quintero ,&nbsp;Raúl Vallejo-Serna","doi":"10.1016/j.rcreue.2024.07.007","DOIUrl":"10.1016/j.rcreue.2024.07.007","url":null,"abstract":"<div><h3>Introduction</h3><p>Transthoracic echocardiography is a useful noninvasive tool in the assessment of cardiac involvement in patients with systemic lupus erythematosus.</p></div><div><h3>Objective</h3><p>We aimed to investigate the main echocardiographic alterations in patients with a diagnosis of systemic lupus erythematosus and to describe the relationship between various disease factors and echocardiographic findings.</p></div><div><h3>Materials and methods</h3><p>We performed a retrospective review of patients with a diagnosis of SLE between 2016 and 2020 at a referral centre. All 98 patients were included, 87% were female, the mean age for the whole population was 35 years (IQR 27.0- 49.7), 40% had a recent diagnosis, 55% with previous or new diagnosis of arterial hypertension, 37% were using steroids at admission.</p></div><div><h3>Results</h3><p>Among the echocardiographic findings, 64.3% had valvular disease, 63% had pericardial involvement, 25.5% systolic function compromise, 27.5% some degree of diastolic dysfunction, 13% ventricular hypertrophy, 46% left atrial enlargement, 87% right ventricular systolic dysfunction, 24.5% some probability of pulmonary hypertension, 3% non-infectious vegetations. The presence of lupus activity was associated with a higher percentage of abnormal echocardiographic findings. There was no significant relationship between disease duration and cardiac abnormalities, anti-DNA and positive antiphospholipid antibodies were more frequently observed in the cardiac involvement group.</p></div><div><h3>Conclusion</h3><p>We consider that echocardiography should be part of the routine evaluation in patients with lupus. Right ventricular systolic dysfunction, pericardial involvement and non-significant valvular disease were the most frequently reported abnormalities.</p></div>","PeriodicalId":101099,"journal":{"name":"Revista Colombiana de Reumatología (English Edition)","volume":"31 3","pages":"Pages 311-317"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142271847","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}